Clinical Trials Logo

Tremor, Essential clinical trials

View clinical trials related to Tremor, Essential.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05234762 Recruiting - Tremor, Essential Clinical Trials

Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential Tremors

Start date: November 21, 2021
Phase: Phase 2
Study type: Interventional

This Pilot Phase 2A study will investigate the safety, tolerability, and pharmacokinetics (PK) of ES-481 in adult patients with essential tremor.

NCT ID: NCT03672266 Recruiting - Alzheimer Disease Clinical Trials

Studies of Brain and Body Interaction

Start date: August 1, 2018
Phase:
Study type: Observational

The goal of this study is to characterize biophysiolgoical signals as a comprehensive profile of the nervous systems in order to understand interactions between the brain and body, while an individual performs naturalistic behaviors (ex. walking, pointing) and while breathing at a slow controlled pace. The investigators aim to study these interactions among a variety of populations, from healthy individuals to those with disorders such as Autism Spectrum Disorder(s), including those who may also have an ADHD (Attention-deficit/hyperactivity disorder) diagnosis, Asperger's Syndrome, Alzheimer's Disease, and/or Fragile X syndrome

NCT ID: NCT03074422 Recruiting - Parkinson Disease Clinical Trials

Effectiveness and Reliability of Hypnosis in Stereotaxy

ERST
Start date: July 1, 2017
Phase: N/A
Study type: Interventional

In certain neurosurgical procedures, the use of a stereotaxic frame is required. It is then possible to set a precise target (depending of the type of the surgery) to be reached by the surgeon. The fixation of the stereotactic frame on the awake patient's head is done under local anesthesia by screwing the frame directly into the skull. This procedure is reported as "painful" to "extremely painful" by patients. The objective of this study is to determine whether the hypnosis is effective in decreasing the pain perceived by the patient during the disposal of the stereotactic frame.